Cargando…
A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
OBJECTIVE: Many studies have drawn their attention to the immunotherapy of bladder urothelial carcinoma in terms of immunologic mechanisms of human body. These include immunogenicity of the tumor cells and involvement of long non-coding RNA (lncRNA). We constructed a necroptosis-related long noncodi...
Autores principales: | Hou, Jian, Lu, Zhenquan, Dong, Runan, Wu, Guoqing, Nie, Haibo, Yang, Guang, Tang, Cheng, Qu, Genyi, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270023/ https://www.ncbi.nlm.nih.gov/pubmed/35814472 http://dx.doi.org/10.3389/fonc.2022.928204 |
Ejemplares similares
-
An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
por: Hou, Jian, et al.
Publicado: (2022) -
Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer
por: Hou, Jian, et al.
Publicado: (2022) -
Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer
por: Qu, Genyi, et al.
Publicado: (2022) -
A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer
por: Hou, Jian, et al.
Publicado: (2022) -
A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)